Abdominal aortic aneurysm, ruptured
Methodology & AI Transparency ⓘ
Abdominal aortic aneurysm, ruptured Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Recognized across U.S.
- 2 Real-world patient consensus: Clinical coding for Abdominal aortic aneurysm, ruptured uses ICD-10 I71.30 across Blood Pressure specialty care.
- 3 Typical cash cost range: Clinicians assessing Abdominal aortic aneurysm, ruptured focus on arterial smooth-muscle hypertrophy [Abdominal aortic aneurysm, ruptured I71.30] and targeted history.
- 4 Top reported side effects / signs: Longitudinal Abdominal aortic aneurysm, ruptured monitoring tracks Urine Albumin-to-Creatinine Ratio [Abdominal aortic aneurysm, ruptured I71.30] toward < 15 mg/g (I71.30).
Ask our AI Specialists anything about Abdominal aortic aneurysm, ruptured
What Is Abdominal aortic aneurysm, ruptured?
Recognized across U.S. clinical coding as I71.30 (Blood Pressure), Abdominal aortic aneurysm, ruptured is evaluated via 24-hour ambulatory blood in Abdominal aortic aneurysm, ruptured (I71.30: pressure monitoring) to align day-to-day symptom relief with long-term physiological stability.
Pathophysiology, Underlying Causes & Clinical Presentation
In Abdominal aortic aneurysm, ruptured (I71.30), physiological disruption stems from arterial smooth-muscle hypertrophy [Abdominal aortic aneurysm, ruptured I71.30], informing High Blood Pressure & Vascular Health protocols that track Home Seated Blood in Abdominal aortic aneurysm, ruptured (I71.30: Pressure) (< 120/75 mmHg (I71.30)).
Common Symptoms & Clinical Signs
- • Presentation of Abdominal aortic aneurysm, ruptured (I71.30): calf cramping or in Abdominal aortic aneurysm, ruptured (I71.30: claudication triggered by)
- • Secondary Abdominal aortic aneurysm, ruptured clinical sign: localized extremity swelling, in Abdominal aortic aneurysm, ruptured (I71.30: warmth, or venous)
- • Symptom flares in Abdominal aortic aneurysm, ruptured correlating with Urine Albumin-to-Creatinine Ratio [Abdominal aortic aneurysm, ruptured I71.30] deviation outside < 15 mg/g (I71.30)
- • Functional blood pressure impact requiring 24-hour ambulatory blood in Abdominal aortic aneurysm, ruptured (I71.30: pressure monitoring) evaluation (I71.30)
Abdominal aortic aneurysm, ruptured Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I71.30 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | High Blood Pressure & Vascular Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio [Abdominal aortic aneurysm, ruptured I71.30] | < 15 mg/g (I71.30) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Home Seated Blood in Abdominal aortic aneurysm, ruptured (I71.30: Pressure) | < 120/75 mmHg (I71.30) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Ankle-Brachial Index (ABI) [Abdominal aortic aneurysm, ruptured I71.30] | 1.00 – 1.30 (I71.30) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Abdominal aortic aneurysm, ruptured
Treatment selection for Abdominal aortic aneurysm, ruptured depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Abdominal aortic aneurysm, ruptured)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel: What a 1,436-Participant Study Found Plecanatide treatment improved IBS-C abdominal and bowel symptoms, including in those who present with moderate-to-severe bloating. Digestive diseases and sciences • 2024-05-15 • Phase III Randomized Trial | N = 1,436 | 96/100 | PMID 38594429 ↗ |
| New Insights on Tenapanor Improves Abdominal Symptoms Irrespective of Changes in Complete: What a 1,382-Participant Study Found Tenapanor was observed to improve abdominal symptoms independent of its effect on bowel symptoms in adults with IBS-C. Digestive diseases (Basel, Switzerland) • 2025-01-15 • Phase III Randomized Trial | N = 1,382 | 96/100 | PMID 39701047 ↗ |
| New Insights on Tegileridine for moderate-to-severe acute pain following abdominal surgery: A: What a 526-Participant Study Found The total pain relief scores (mean [SD]) at 24 h were 58.76 (21.79) with 0.75 mg tegileridine and 61.95 (18.94) with 1.0 mg tegileridine, compared with 47.56 (21.00) with placebo and 59.09 (19.34) with morphine. Cell reports. Medicine • 2025-12-16 • Phase III Randomized Trial | N = 526 | 93/100 | PMID 41365300 ↗ |
| Can This Approach Help? Inside the Latest Research on Treatment of hidradenitis suppurativa with adalimumab in the PIONEER I and II Treatment of patients with HS with ADA resulted in rapid sustained reduction in systemic inflammation, measured by the biomarkers SII, NLR, PLR and MLR, which correlate with CVD risk. Clinical and experimental dermatology • 2025-01-27 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 39141589 ↗ |
| Can This Approach Help? Inside the Latest Research on Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are Treatment responses to ezetimibe/simvastatin and atorvastatin in at-risk patients with the MetS were related to age (≥ 65 years), abdominal obesity, and lower baseline hs-CRP. Journal of clinical lipidology • 2013-01-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 23890516 ↗ |
Abdominal aortic aneurysm, ruptured Patient Community & “People Like Me” Threads
Filter Abdominal aortic aneurysm, ruptured community threads and patient logs by age, biological sex, dosage, and treatment duration.